Dr. Trotter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3410 Worth St
Ste 860
Dallas, TX 75246Phone+1 214-820-8500Fax+1 214-820-8168
Education & Training
Duke University HospitalFellowship, Gastroenterology, 1992 - 1996
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1989 - 1992
Emory University School of MedicineClass of 1989
Certifications & Licensure
MT State Medical License 2024 - 2026
UT State Medical License 2023 - 2026
CO State Medical License 1999 - 2025
ID State Medical License 2024 - 2025
NV State Medical License 2024 - 2025
TX State Medical License 1992 - 2025
NC State Medical License 1996 - 2000- American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Use of Sanvar® With Endoscopic Treatment for the Control of Acute Variceal Bleeding Start of enrollment: 2006 May 01
- Evaluation of Liver Disease With Elastography Measurements in Patients Undergoing Liver Transplant Surgery Start of enrollment: 2013 Jun 01
- A Phase 1 Study of LJPC-501 in Patients With Hepatorenal Syndrome Start of enrollment: 2014 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 56 citationsGenetic Risk Factors for Hepatopulmonary Syndrome in Patients With Advanced Liver DiseaseKari E. Roberts, Steven M. Kawut, Michael J. Krowka, Robert S. Brown, James F. Trotter
Gastroenterology. 2010-07-01 - 182 citationsNGM282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients With Nonalcoholic Steatohepatitis.Stephen A. Harrison, Stephen J. Rossi, Angelo H. Paredes, James F. Trotter, Mustafa R. Bashir
Hepatology. 2020-04-01 - 211 citationsCilofexor, a Nonsteroidal FXR Agonist, in Patients With Noncirrhotic NASH: A Phase 2 Randomized Controlled TrialKeyur Patel, Stephen A. Harrison, Magdy Elkhashab, James F. Trotter, Robert Herring
Hepatology. 2020-07-01
Journal Articles
- Impact of Prior Bariatric Surgery on Perioperative Liver Transplant OutcomesSumeet K Asrani, James Trotter, Goran Klintmalm, Liver transplantation
- A Model for Glomerular Filtration Rate Assessment in Liver Disease (GRAIL) in the Presence of Renal DysfunctionBernard Fischbach, James F Trotter, W R Kim, Stevan A Gonzalez, Goran Klintmalm, Sumeet K Asrani, Michael Emmett, Ranjeeta Bahirwani, Josh Levitsky, Mitra K Nadim, Hepatology
- Trends in Chronic Liver Disease-Related Hospitalizations: A Population-Based StudySumeet K Asrani, James Trotter, Jayant Talwalkar, Fasiha Kanwal, Nature
Press Mentions
Why CDC Wants More People Screened for Hepatitis CJuly 26th, 2020- Hepatocellular Carcinoma Recurrence and Death Following Living and Deceased Donor Liver TransplantationJuly 23rd, 2020
Transplantation and Undocumented Immigrants: A Tale of Two StatesSeptember 26th, 2019- Join now to see all
Grant Support
- Phase II Trial Assess Sfty Of Imnosprsn W/Drawal In Liver Trnsplnt Recip W/Hep CNational Center For Research Resources2006–2008
- Campth-1h&Tacrolimus Followed By Immunosuppress Withdrawal In Liver TransplantsNational Center For Research Resources2006–2008
- A2all: Adult-To-Adult Living Donor Liver Transplant Cohort StudyNational Center For Research Resources2006–2008
- Adult To Adult Living Donor Liver Transplantation Cohor*National Institute Of Diabetes And Digestive And Kidney Diseases2002–2008
- Treatment Of Chronic Hepatitis C: Peg-Intron And Ribavirin With Or Without KattNational Center For Research Resources2005–2006
- Treatment Of Chronic Hepatitis C: Peg-Intron &RibavirinNational Center For Research Resources2004
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
